La Jolla Pharmaceutical Co
LJPCDelisted Aug 22, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000920465
La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding La Jolla Pharmaceutical Co changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 54 | 44 | −10 |
| Shares | 17.8M | 16.7M | −1.04M (−5.9%) |
| Value | $70.9M | $77.8M | +$6.89M (+9.7%) |
New holders (5)
Institutions that held La Jolla Pharmaceutical Co at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 11,582 | $54.0K | 0.00% |
| Group One Trading, L.P. | 8,127 | $38.0K | 0.00% |
| Captrust Financial Advisors | 2,600 | $12.0K | 0.00% |
| Amplius Wealth Advisors, LLC | 1,255 | $5.00K | 0.00% |
| Tyler-Stone Wealth Management | 500 | $2.00K | 0.00% |
Sold out (15)
Institutions that held La Jolla Pharmaceutical Co at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Boxer Capital, LLC | 890,700 | $3.55M |
| Jacobs Levy Equity Management, Inc | 158,455 | $632.0K |
| Ergoteles LLC | 57,083 | $228.0K |
| HRT Financial LP | 45,461 | $181.0K |
| Gsa Capital Partners LLP | 26,143 | $104.0K |
| HighVista Strategies LLC | 25,493 | $102.0K |
| Virtu Financial LLC | 21,258 | $85.0K |
| Signaturefd, LLC | 10,000 | $40.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 10,094 | $40.0K |
| Meeder Asset Management Inc | 4,282 | $17.0K |
| FMR LLC | 1,000 | $4.00K |
| Salem Investment Counselors Inc | 850 | $3.00K |
| Nisa Investment Advisors, LLC | 590 | $2.00K |
| Harbour Investments, Inc. | 322 | $1.00K |
| Deutsche Bank AG | 35 | $0 |